Study of Biomarker From Blood and Tissue of Head and Neck Carcinoma

NCT01171235 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2010-07-28

No results posted yet for this study

Summary

The aim of the study is to find for one or more serum or tissue markers of molecular biology in head and neck cancer patients used for early diagnosis, predicting prognosis and being sensitive to chemotherapy and radiotherapy

Conditions

  • Laryngeal Neoplasms
  • Pharyngeal Neoplasms

Sponsors & Collaborators

  • Southern Medical University, China

    lead OTHER

Principal Investigators

  • Ping Xiang Li, doctor · E.N.T department of NanFang hospital

Eligibility

Min Age
15 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2011-12-31
Completion
2012-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01171235 on ClinicalTrials.gov